Beyond its anticancer activity against angiogenesis, apatinib was found to reverse multidrug resistance by decreasing expression of P-glycoprotein (ABCB1) and BC resistance protein (ABCG2) in vitro. The gene discussed is ABCB1; the disease is breast cancer.